Purtroppo contro il nostro Flavio Cobolli, ma gioisco della vittoria di Alexander Zvevev nella finale di tennis del Roland Garros.
Zverev ha il diabete di tipo 1 dall'età di 4 anni.
Chiaro che ha fisico, preparazione, cervello.
Ma il diabete non l'ha limitato.
Anzi
fra i tanti ricordi della mia vita, c’è anche quello di aver cantato Sapore di Sale con @GinoPaoli_ al Parco della Musica.
Che onore! Che emozione!
Era un evento per la Giornata Mondiale del Diabete.
Grazie Gino. Buon viaggio.
@andreavianel tutti gli italiani sono d’accordo che la riforma dell’articolo 5 sia stato un tragico errore.
Tutti i partiti italiani sono d’accordo che non si debba tornare indietro sull’articolo 5.
In altre parole, i partiti non rappresentano gli italiani
nessuno
@DanielJDrucker@DiabetologiaJnl The question mark is appropriate. Any intervention reducing HbA1c and BW improves #insulin sensitivity. Lack of correlation between changes in GIR and other variables is due to the study being underpowered, with at least 3-4 outliers. Tirze should be compared with other drugs.
Mia figlia Marta è ad Amsterdam.
Mia figlia Chiara è a Ginevra.
Ma torneranno in tempo per Natale.
Io sono già pronto per accoglierle!
Buon Natale a tutti.
https://t.co/ti67aznrfu
"My #stroke left me unable to speak. As a journalist, words have always been my banner, my identity, and the tool of my trade, so losing that ability was a significant blow" – Andrea @andreavianel shares his journey from silence to recovery.
29/10 is #WorldStrokeDay
I would like to thank prof. Pop-Busui for dedicating her award to her missing friend prof. Simona Frontoni (see the slide).
But Simona was there, with her.
Simona is with all of us.
I would like to thank prof. Pop-Busui for dedicating her award to her missing friend prof. Simona Frontoni.
But Simona was there, with her.
Simona is with all of us.
Huge congrats to Prof. Rodica Pop-Busui for winning the 39th CAMILLO GOLGI LECTURE! Prof. Pop-Busui’s endeavours in and contributions to the field of diabetes complications are mountainous⛰️🤩👏🏼
Happy and honoured to represent @novonordisk sponsoring the prize🙏🏼
#ADA2024: we presented 2 Oral Communications (dr. Morciano, photo, and dr. Di Giuseppe) + 3 Posters (drs. Avolio, Ciccarelli and Soldovieri). I thank @ADA_DiabetesPro and @AmDiabetesAssn for giving my group the opportunity to present our data and to be part of the best science!
@DanielJDrucker The possible effects of combining SGLT-2i with GLP-1 RA now become the most interesting question. Clearly the FLOW study cannot provide a definitive answer. However, the effect of adding sema seems really absent...
after a long battle against an opposing reviewer, the editor proposed that I break the impasse by resubmitting the article as a Research Letter. After a long editing process, it was submitted and immediately accepted. It's a letter, but it's still on JCI!
https://t.co/E2I1VbtmJt
3° G.Meta Forum al cuore del diabete
Roma, 8.9 marzo 2024 @Gemelli
Un aperto dibattito con esperti SID, SIC, SIN (e non solo) per ragionare, approfondire, discutere, insieme con numerosi selezionati discussant, sulle molte domande ancora aperte.
Iscriviti https://t.co/AcnPaTRYSk
Today I threw away 25 years of science
(in recycling). Over 1000 volumes.
With Simona, having returned from the States in 1990, we subscribed to Diabetes, Diabetes Care, Diabetologia, New England, JCI, and others.
Then the web prevailed.
How sad!
SGLT-2i lose all their glucose-lowering efficacy in presence of hypoglycemia. This makes them an ideal companion to insulin treatment, whatever the type of diabetes. With MAJOR cardio-renal benefits.
https://t.co/9bd7ewBtGh @Filip_Knop@DiabetesCareADA@ADA_DiabetesPro